Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Findings from University of Texas advance knowledge in breast cancer
June 11th, 2009
According to a study from the United States, "The ubiquitously expressed 14-3-3 proteins are involved in numerous important cellular functions. The loss of 14-3-3 sigma is a common event in breast cancer; however, the role of other 14-3-3s in breast cancer is unclear." "Recently, we found that 14-3-3 zeta overexpression occurs in early stage breast diseases and contributes to transformation of human mammary epithelial cells. Here, we show that 14-3-3 zeta overexpression also persisted in invasive ductal carcinoma and contributed to the further progression of breast cancer. To examine the clinical effect of 14-3-3 zeta overexpression in advanced stage breast cancer, we...
Source: Women's Health Weekly (2009-06-11)
|
